v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Treasury Stock Amount
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning balance (in shares) at Dec. 31, 2024 [1] 164,087,000          
Beginning balance at Dec. 31, 2024 $ 19 [1] $ 769,866 $ (1) $ 21 $ (658,722) $ 111,183
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation   247       247
Foreign currency translation adjustment       4   4
Unrealized loss on available-for-sale securities       (14)   (14)
Net Income (Loss)         (11,250) (11,250)
Ending balance (in shares) at Mar. 31, 2025 [1] 164,087,000          
Ending balance at Mar. 31, 2025 $ 19 [1] 770,113 (1) 11 (669,972) 100,170
Beginning balance (in shares) at Dec. 31, 2024 [1] 164,087,000          
Beginning balance at Dec. 31, 2024 $ 19 [1] 769,866 (1) 21 (658,722) 111,183
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustment           (11)
Unrealized loss on available-for-sale securities           (16)
Net Income (Loss)           (19,099)
Ending balance (in shares) at Jun. 30, 2025 [1] 164,087,000          
Ending balance at Jun. 30, 2025 $ 19 [1] 770,067 (1) (6) (677,821) 92,258
Beginning balance (in shares) at Mar. 31, 2025 [1] 164,087,000          
Beginning balance at Mar. 31, 2025 $ 19 [1] 770,113 (1) 11 (669,972) 100,170
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation   (46)       (46)
Foreign currency translation adjustment       (15)   (15)
Unrealized loss on available-for-sale securities       (2)   (2)
Net Income (Loss)         (7,849) (7,849)
Ending balance (in shares) at Jun. 30, 2025 [1] 164,087,000          
Ending balance at Jun. 30, 2025 $ 19 [1] 770,067 (1) (6) (677,821) $ 92,258
Beginning balance (in shares) at Dec. 31, 2025 164,087,000 [2]         163,519,801 [3]
Beginning balance at Dec. 31, 2025 $ 19 [2] 770,423 (1) 39 (712,469) $ 58,011
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation   155       155
Foreign currency translation adjustment       33   33
Unrealized loss on available-for-sale securities       (3)   (3)
Net Income (Loss)         (5,938) (5,938)
Ending balance (in shares) at Mar. 31, 2026 [2] 164,087,000          
Ending balance at Mar. 31, 2026 $ 19 [2] 770,578 (1) 69 (718,407) $ 52,258
Beginning balance (in shares) at Dec. 31, 2025 164,087,000 [2]         163,519,801 [3]
Beginning balance at Dec. 31, 2025 $ 19 [2] 770,423 (1) 39 (712,469) $ 58,011
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustment           44
Unrealized loss on available-for-sale securities           (4)
Net Income (Loss)           $ (12,838)
Ending balance (in shares) at Jun. 30, 2026 165,428,000 [2]         164,860,955 [3]
Ending balance at Jun. 30, 2026 $ 19 [2] 770,980 (1) 79 (725,307) $ 45,770
Beginning balance (in shares) at Mar. 31, 2026 [2] 164,087,000          
Beginning balance at Mar. 31, 2026 $ 19 [2] 770,578 (1) 69 (718,407) 52,258
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation   518       518
Issuance of common stock upon settlement of restricted stock units (in shares) [2] 1,926,000          
Tax withholdings on settlement of equity awards   (116)       (116)
Tax withholding on settlement of equity awards (in shares) [2] (585,000)          
Foreign currency translation adjustment       11   11
Unrealized loss on available-for-sale securities       (1)   (1)
Net Income (Loss)         (6,900) $ (6,900)
Ending balance (in shares) at Jun. 30, 2026 165,428,000 [2]         164,860,955 [3]
Ending balance at Jun. 30, 2026 $ 19 [2] $ 770,980 $ (1) $ 79 $ (725,307) $ 45,770
[1] Shares issued and outstanding exclude 738,000 Sponsor Shares subject to vesting requirements.
[2] Shares issued and outstanding exclude 738,000 unvested Sponsor Shares held by the Sponsor as of January 1, 2026 and March 31, 2026; such shares were forfeited and cancelled on June 4, 2026, and accordingly, are no longer outstanding as of June 30, 2026.
[3] On June 4, 2026, the 738,000 shares subject to vesting requirements held by TS Innovation Acquisitions Sponsor, L.L.C. (the “Sponsor”) related to the 2021 business combination (the “2021 Business Combination”) (such shares, the “Sponsor Shares”) were forfeited and cancelled pursuant to the Sponsor Agreement dated January 24, 2021. Accordingly, such shares are no longer outstanding as of June 30, 2026. Shares issued and outstanding as of December 31, 2025 exclude the unvested Sponsor Shares held by the Sponsor.